Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
Wednesday, June 04, 2025TriLink BioTechnologies TriLink a Maravai LifeSciences company NASDAQ MRVI and global provider of life science reagents and services has signed a nonexclusive License and Supply Agreement with Quantoom Biosciences
Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions
Wednesday, June 04, 2025FUJIFILM Corporations Life Sciences Group companies a portfolio of businesses offering products services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization
ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
Wednesday, June 04, 2025ThinkCyte a life science company pioneering advanced AIpowered cell analysis and sorting technologies today announced the precommercial launch of MorphoScan Cloud its new cloudbased platform designed for flexible data access faster processing and adv...
Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan
Wednesday, June 04, 2025Telix today announces that it has established Telix Manufacturing Solutions TMS in Yokohama Japan Telixs first cyclotron facility in the Asia Pacific region represents a significant milestone in the Companys global manufacturing strategy
Venus Remedies Secures Ukrainian GMP Renewal, Strengthening Global Pharmaceutical Presence
Tuesday, June 03, 2025Venus Remedies Limited a leading global pharmaceutical company has successfully renewed its Good Manufacturing Practices GMP certification from Ukraines State Service on Medicines and Drugs Control SMDC
Genentech’s Tecentriq Combined With Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer
Tuesday, June 03, 2025Genentech a member of the Roche Groupannounced today positive results from the Phase III IMforte study of Tecentriq atezolizumab in combination with lurbinectedin Zepzelca as a firstline maintenance treatment for people with extensivestage small cell...
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
Tuesday, June 03, 2025Thermo Fisher Scientific Inc NYSE TMO the world leader in serving science today announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometer MS and the Thermo Scientific Orbitrap Excedion Pro mass spectrometer MS to help push...
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
Tuesday, June 03, 2025SCIEX a global leader in life science analytical technologies and operating company of Danaher Corporation and Evosep Biosystems a global leader in proteomics solutions enter a reseller agreement to cosell SCIEX mass spectrometry systems with the new...
ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
Tuesday, June 03, 2025ASP Isotopes Inc and Isotopia Molecular Imaging Ltd have entered into a strategic agreement to secure the supply of Gadolinium Gd a critical precursor isotope for producing Terbium Tb
XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS
Tuesday, June 03, 2025XellSmart Biomedical Co Ltdis a leading biotechnology company dedicated to the development of innovative iPSCderived cell therapies To date the company has received seven Investigational New Drug IND
